| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |